Samarium-153-ethylene diamine tetramethylene phosphonate, a beta-emitting bone-targeted radiopharmaceutical, useful for patients with osteoblastic bone metastases (Q37103630)
Jump to navigation
Jump to search
scientific article published on 13 August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Samarium-153-ethylene diamine tetramethylene phosphonate, a beta-emitting bone-targeted radiopharmaceutical, useful for patients with osteoblastic bone metastases |
scientific article published on 13 August 2013 |
Statements
1 reference
Samarium-153-ethylene diamine tetramethylene phosphonate, a beta-emitting bone-targeted radiopharmaceutical, useful for patients with osteoblastic bone metastases (English)
1 reference
John Longo
1 reference
Stephen Lutz
1 reference
Candice Johnstone
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference